Caresyntax Stock
Caresyntax is a vendor neutral data-driven surgery platform that makes surgery smarter by reducing variability and improving efficency.
Sign up today and learn more about Caresyntax Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Caresyntax Stock
Caresyntax is a digital surgery platform that enables OR teams to predict and improve surgical performance. Its enterprise-grade digital surgery platform delivers insights to improve patient outcomes by using proprietary software and AI to analyze large volumes of video, audio, images, device data, clinical, and operational data in and around the OR. Caresyntax insights help surgeons benchmark and improve their care, hospital administrators use surgical resources more efficiently, medical device companies advance better products, and insurance companies understand risk and devise more tailored policies. The software is used in more than 4,000 operating rooms worldwide, has supported more than 30,000 surgeons, and improved care for more than 2 million patients.
Investors
BlackRock
Databricks, Rivian, Relativity Space, View, Carbon Health, Scopely, Snyk, Jawbone, MessageBird, DataRobot
Whiz Partners
Plug and Play
BigID, ApplyBoard, Caresyntax, Genapsys, Albert, Beyond Pricing
Optum Ventures
Mitsubishi Corporation
Funding History
September 2017 | $11.9M |
---|---|
June 2018 | $20.0M |
December 2019 | $45.6M |
September 2021 | $130M |
Management
Co-Founder and CEO
Dennis Kogan
Chief Financial Officer
Claire Masterson
Press
businesswire - Jan, 8 2024
Caresyntax announces launch of novel Real World Evidence (RWE) program and software portfolio of digital catalysts for commercial acceleration of Medtech partnersprnewswire - Dec, 7 2023
Caresyntax Announces Strategic Collaboration with AAICO to expand AI-based solutions in healthcareseekingalpha - Jun, 19 2023
Caresyntax and ProAssurance join hands for surgical intelligencemassdevice - Sep, 18 2021
Caresyntax brings Series C funding to $130Mbloomberg - Sep, 17 2021
Caresyntax Gets BlackRock Investment in Upsized Funding Round